The upcoming report from CareDx (CDNA) is expected to reveal quarterly loss of $0.19 per share, indicating a decline of 72.7% compared to the year-ago period. Analysts forecast revenues of $63.63 ...
CareDx (CDNA) reported $86.68 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 6.1%. EPS of $0.10 for the same period compares to $0.25 a year ago. The ...
Craig-Hallum analyst Alexander Nowak maintained a Hold rating on CareDx (CDNA – Research Report) today. The company’s shares closed yesterday at $9.64. Nowak covers the Healthcare sector, focusing on ...
Crypto.com has secured approval from the Commodity Futures Trading Commission (CFTC) to offer margined derivatives, including ...
CareDx, Inc. (NASDAQ:CDNA) faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company’s expanding transplant solutions ...
In a report released on December 28, Mark Massaro from BTIG maintained a Hold rating on CareDx (CDNA – Research Report). The company’s shares closed last Friday at $12.00. Massaro covers the ...
Back in 2020, AMD announced it was splitting its post-GCN architecture into RDNA for gaming, with CDNA for its data center GPUs, with CDNA later being the architecture of its Radeon Instinct AI ...
Resultaten die mogelijk niet toegankelijk zijn voor u worden momenteel weergegeven.
Niet-toegankelijke resultaten verbergen
Feedback